AI in drug discovery

Lucid Diligence Brief - Tech

Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration

Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Insilico and Hygtia partner on brain-penetrant NLRP3 inhibitor

Lucid Diligence Brief: Insilico and Hygtia partner on brain-penetrant NLRP3…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Signet Therapeutics RMB 80 million Series A for organoids + AI in oncology

Lucid Diligence Brief: Signet Therapeutics RMB 80 million Series A for…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance

Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Today—November 6, 2025

This week’s cell and gene therapy update spotlights key developments,…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration

Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.